Previous close | 73.80 |
Open | N/A |
Bid | 82.20 |
Ask | 85.85 |
Strike | 220.00 |
Expiry date | 2025-12-19 |
Day's range | 73.80 - 73.80 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AbbVie's (ABBV) Skyrizi is now approved for four indications across immune-mediated inflammatory diseases.